Task: Answer the following question about the molecule with SMILES Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1.
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Completion: Approved
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1
Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1
6-phenylpteridine-2,4,7-triamine
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.